< Current issue
Dermatopathology: Practical & Conceptual January - March 2003
Contrary View on Behalf of Patients: Sentinel lymph node biopsy has no benefit for patients with primary cutaneous melanoma: An assertion based on comprehensive, critical analysis.
Neil Medalie, M.D.
A. Bernard Ackerman, M.D.
1. Elective Lymph Node Dissection: Historical Perspective
2. Diagnosis of Metastasis of Melanoma in Sentinel Nodes: Past and Present.
3. Evolution of Methods for Mapping Lymph Nodes: From Determination of a Regional Node Basin to Detection of a Sentinel Node.
4. Sentinel Node Biopsy: Standard of Care?
5. Concepts regarding the mechanisms of dissemination of melanoma
6. Metastatic Melanoma: No systemic therapy currently available is effective.
7. A Last Word – Sentinel node biopsy provides no benefit to patients and, therefore, should be abandoned now
sentinel lymph node biopsy
Elective lymph node dissection: Historical perspective
Diagnosis of metastasis of melanoma in regional lymph nodes: Past and present
Evolution of methods for mapping lymph nodes: From determination of a regional lymph node basin to detection of a sentinel lymph node
Sentinel lymph node biopsy: Standard of care?
Concepts regarding mechanisms of dissemination of melanoma
Metastatic melanoma: No systemic adjuvant therapy currently available is effective
A last word—Sentinel lymph node biopsy provides no benefit to patients with melanoma and, therefore, should be abandoned now
This site is made possible in part by:
Copyright © Derm101.com. All Rights Reserved.